Dhanak Dashyant
- SEC CIK
- 0001760682
No open-market purchases or sales filed in the past year.
Current role at each company
- DCPH Deciphera Pharmaceuticals, Inc.EVP & Chief Scientific Officeras of Jun 11, 2024
- INCY Incyte CorpEVP & Chief Scientific Officeras of Jul 18, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dhanak Dashyant as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INCY Incyte Corp
EVP & Chief Scientific Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2023 (view filing) | Jan 26 | 4 days | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −2.42K | $85.00 | −$205.6K | −4.3%53.3K after | |
| Oct 4, 2021 (view filing) | Oct 1 | 3 days | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −389 | $68.67 | −$26.7K | −1.2%31.3K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −388 | $76.71 | −$29.8K | −1.2%31.7K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −389 | $77.49 | −$30.1K | −1.2%32.0K after | |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Dhanak DashyantEVP & Chief Scientific Officer | SSale | −396 | $84.09 | −$33.3K | −1.5%26.1K after |